Fesoterodine
Fesoterodine is a pharmaceutical drug with 31 clinical trials. Historical success rate of 93.3%.
Success Metrics
Based on 28 completed trials
Phase Distribution
Phase Distribution
6
Early Stage
4
Mid Stage
14
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
93.3%
28 of 30 finished
6.7%
2 ended early
0
trials recruiting
31
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Treatment Persistence Among Patients With Overactive Bladder: A Retrospective Secondary Data Analysis in Asia Oceania
Fall Prevention in Older Adults With OAB
A Study of Effects of Fesoterodine in Men at High Risk for Overactive Bladder/Detrusor Overactivity Post Robotic-Assisted Lap. Prostatectomy
A Registry Study of Patients Initiating a Course of Drug Therapy for Overactive Bladder in Taiwan, Korea and China
Fesoterodine on Urgency Episodes in Parkinson's Disease Population
Clinical Trials (31)
Treatment Persistence Among Patients With Overactive Bladder: A Retrospective Secondary Data Analysis in Asia Oceania
Fall Prevention in Older Adults With OAB
A Study of Effects of Fesoterodine in Men at High Risk for Overactive Bladder/Detrusor Overactivity Post Robotic-Assisted Lap. Prostatectomy
A Registry Study of Patients Initiating a Course of Drug Therapy for Overactive Bladder in Taiwan, Korea and China
Fesoterodine on Urgency Episodes in Parkinson's Disease Population
Fesoterodine for Amelioration of Autonomic Dysreflexia (AD) Following Spinal Cord Injury (SCI)
Extension Study of Fesoterodine for Overactive Bladder Syndrome in Children.
Fesoterodine and Oxybutynin XL for Overactive Bladder Syndrome in Children
This Is An Open-Label Study To Evaluate Fesoterodine Plus "Your Way" Patient Support Plan In Patients With Symptoms Of Overactive Bladder
A Trial To Evaluate The Efficacy And Safety Of Fesoterodine In Patients With Symptoms Of Overactive Bladder Including Nocturnal Urinary Urgency
Study In Patients With Overactive Bladder Treated With Toviaz® After Failure Of Previous Therapy
A Bioequivalence Study Of 4 Mg Fesoterodine Extended-Release Tablets (Toviaz™) In Healthy Subjects
A Bioequivalence Study Of 8 Mg Fesoterodine Extended-Release Tablets (Toviaz™) In Healthy Subjects
Comparison Between Desmopressin and Fesoterodine for Treatment of Night Time Voiding in Women Aged 65 and Older
Comparative Urine Proteomic Studies of Overactive Bladder in Humans
Post Marketing Surveillance Of Fesoterodine In Filipino Patients With Over Active Bladder
Local, Open-Label, Extension Trial Of The Efficacy And Safety Of Fesoterodine In Elderly Patients With Overactive Bladder
A Study Of Efficacy And Safety Of Fesoterodine In Vulnerable Elderly Subjects With Overactive Bladder
Solifenacin Succinate Versus Fesoterodine A Comparison Trial for Urgency Symptoms
Comparison of Efficacy and Safety Between Imidafenacin and Fesoterodine in Patients With Overactive Bladder
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 31